Strides Pharma Reports Profit Surge Amid Global Growth
Published on: May 18, 2026, 3:23 p.m. | Source: Devdiscourse
Strides Pharma Science Ltd reported a consolidated net profit rise of 51% to Rs 129.28 crore for Q4 ending March 31, 2026. Strong growth in markets outside the US contributed, with revenue rising to Rs 1,323.47 crore. The company maintains focus on profitability amidst global challenges.
